PURPOSE-FIRST INVESTING

A venture fund dedicated to accelerating innovations in blood and cellular therapies, and related technologies

NYBC Ventures is focused on a humanitarian & fiscal ROI, fostering New York Blood Center's mission-oriented innovation.

AREAS OF FOCUS

We invest in therapeutics, devices and innovative technologies addressing the most pressing challenges in our areas of focus.

CELL THERAPY

TRANSFUSION MEDICINE

BENIGN HEMATOLOGY

INFECTIOUS DISEASE

KEY INVESTMENT STRATEGIES

Working with NYBC Ventures goes beyond capital. We provide access to world-renowned researchers and their labs, cell manufacturing capacity, and source materials.

EXTERNAL INNOVATIONS

Early-stage companies pursuing advancements in blood-related and cellular therapeutics & technologies

JOINT
VENTURE

Companies that would benefit from a partnership with Lindsley F. Kimball Research Institute (LFKRI) researchers and cell manufacturing and sourcing capabilities

INTERNAL INNOVATIONS

Discoveries emerging from New York Blood Center research labs